Scramble to fend off takeover: Allergan vs. Valeant

Valeant Pharmaceuticals International; Market Cap. (as of 3/10/2014): $42.9bn Allergan Inc.; Market Cap. (as of 3/10/2014): $53.64bn As low debt obligations alongside large cash holdings and patent expiration liabilities continue to foster a conducive environment for M&A activity in the pharmaceutical and biotech industry another multi-billion dollar struggle has emerged: Read more…

A spoonful of premium makes the medicine go down: Merck & the latest mega-merger in the healthcare sector

Merck KGaA, Market Cap (as of 26/09/2014): €31.4bn Sigma-Aldrich Corp., Market Cap (as of 26/09/2014): $16.2bn On September 22, 2014, the German drug and chemicals company Merck KGaA announced a definitive agreement under which it will acquire the US-based leading life science consumables supplier Sigma-Aldrich for $17bn, creating one of Read more…

Siemens “DresseS” up for US shale gas boom

Siemens AG, Market Cap (as of 26/09/2014): €83.16bn Dresser-Rand Group Inc., Market Cap (as of 26/09/2014): $6.3bn Siemens AG (NYSE:SI), the Munich-based global powerhouse in electronics and electrical engineering, has agreed to acquire Dresser-Rand Group Inc. (NYSE:DRC), the Houston-based leading supplier of equipment for the oil and gas sector. According Read more…

ICE still hot in the market: SuperDerivatives to be acquired for $350m

Intercontinental Exchange Inc, Market Cap (as of 19/09/2014): $23.45bn Intercontinental Exchange (NYSE: ICE), announced on September 5, 2014 that it has entered into a definitive agreement to acquire SuperDerivatives, a leading provider of risk management analytics, financial market data and valuation services. The acquisition will accelerate the expansion of ICE’s Read more…